| dc.contributor.author | Sturzu, Alexander |  | 
| dc.contributor.author | Sheikh, Sumbla |  | 
| dc.contributor.author | Klose, Uwe |  | 
| dc.contributor.author | Echner, Hartmut |  | 
| dc.contributor.author | Kalbacher, Hubert |  | 
| dc.contributor.author | Deeg, Martin |  | 
| dc.contributor.author | Horger, Marius |  | 
| dc.contributor.author | Ernemann, Ulrike |  | 
| dc.contributor.author | Heckl, Stefan |  | 
| dc.contributor.author | Nägele, Thomas |  | 
| dc.date.accessioned | 2014-03-03T15:23:41Z |  | 
| dc.date.available | 2014-03-03T15:23:41Z |  | 
| dc.date.issued | 2012 |  | 
| dc.identifier.issn | 0167-6997 |  | 
| dc.identifier.uri | http://hdl.handle.net/10900/42749 |  | 
| dc.language.iso | en | en | 
| dc.publisher | Springer | de_DE | 
| dc.relation.uri | http://dx.doi.org/10.1007/s10637-011-9781-7 | de_DE | 
| dc.rights | info:eu-repo/semantics/closedAccess |  | 
| dc.subject.ddc | 610 | de_DE | 
| dc.title | Using the neurotransmitter serotonin to target imaging agents to glioblastoma cells | de_DE | 
| dc.type | Article | de_DE | 
| utue.quellen.id | 20140226071329_00267 | de_DE | 
| utue.publikation.seiten | 2141-2147 | de_DE | 
| utue.personen.roh | Sturzu, Alexander |  | 
| utue.personen.roh | Sheikh, Sumbla |  | 
| utue.personen.roh | Klose, Uwe |  | 
| utue.personen.roh | Echner, Hartmut |  | 
| utue.personen.roh | Kalbacher, Hubert |  | 
| utue.personen.roh | Deeg, Martin |  | 
| utue.personen.roh | Naegele, Thomas |  | 
| utue.personen.roh | Horger, Marius |  | 
| utue.personen.roh | Ernemann, Ulrike |  | 
| utue.personen.roh | Heckl, Stefan |  | 
| dcterms.isPartOf.ZSTitelID | Investigational New Drugs | de_DE | 
| dcterms.isPartOf.ZS-Issue | 6 | de_DE | 
| dcterms.isPartOf.ZS-Volume | 30 | de_DE | 
| utue.fakultaet | 04 Medizinische Fakultät | de_DE | 
| utue.fakultaet | 07 Mathematisch-Naturwissenschaftliche Fakultät | de_DE |